These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure. Liggett SB; Cresci S; Kelly RJ; Syed FM; Matkovich SJ; Hahn HS; Diwan A; Martini JS; Sparks L; Parekh RR; Spertus JA; Koch WJ; Kardia SL; Dorn GW Nat Med; 2008 May; 14(5):510-7. PubMed ID: 18425130 [TBL] [Abstract][Full Text] [Related]
16. The evolving impact of g protein-coupled receptor kinases in cardiac health and disease. Sato PY; Chuprun JK; Schwartz M; Koch WJ Physiol Rev; 2015 Apr; 95(2):377-404. PubMed ID: 25834229 [TBL] [Abstract][Full Text] [Related]
17. GRK2 and GRK5 as therapeutic targets and their role in maladaptive and pathological cardiac hypertrophy. Lieu M; Koch WJ Expert Opin Ther Targets; 2019 Mar; 23(3):201-214. PubMed ID: 30701991 [TBL] [Abstract][Full Text] [Related]
18. Myocardial G protein-coupled receptor kinases: implications for heart failure therapy. Iaccarino G; Lefkowitz RJ; Koch WJ Proc Assoc Am Physicians; 1999; 111(5):399-405. PubMed ID: 10519160 [TBL] [Abstract][Full Text] [Related]
19. betaARKct: a therapeutic approach for improved adrenergic signaling and function in heart disease. Brinks H; Koch WJ J Cardiovasc Transl Res; 2010 Oct; 3(5):499-506. PubMed ID: 20623214 [TBL] [Abstract][Full Text] [Related]
20. G Protein-Coupled Receptor Kinase 2 (GRK2) and 5 (GRK5) Exhibit Selective Phosphorylation of the Neurotensin Receptor in Vitro. Inagaki S; Ghirlando R; Vishnivetskiy SA; Homan KT; White JF; Tesmer JJ; Gurevich VV; Grisshammer R Biochemistry; 2015 Jul; 54(28):4320-9. PubMed ID: 26120872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]